UroGen Pharma (URGN) Revenue (2017 - 2026)
UroGen Pharma (URGN) posted Revenue of $72.46 million for Q2 2026, up 199.2% from $24.22 million a year earlier and up 42.2% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at UroGen Pharma was $188.73 million, up 100.3% year-over-year; for FY2025, it was $109.79 million, up 21.4% from FY2024.
- Annual Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 56.2% (FY2020 to FY2025).
- In prior years, UroGen Pharma's Revenue was $90.4 million in FY2024 (+9.3%), $82.71 million in FY2023 (+28.5%), $64.36 million in FY2022 (+34.0%) and $48.04 million in FY2021 (+307.2%).
- The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q1 2017.
- On a year-over-year basis, Revenue has increased in each of the last 20 quarters, with growth averaging 57.2% over the last eight quarters.
- The year-over-year growth in Revenue has ranged between 3.4% (Q2 2024) and 228.0% (Q3 2021) over the last five years.
- According to Business Quant data, Revenue for the three prior quarters was $50.96 million (Q1 2026), $37.84 million (Q4 2025) and $27.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | UroGen Pharma | 1.99 Bn | 1.49 Bn | 65.88 Mn | 72.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.46 Mn |
| Mar 31, 2026 | 50.96 Mn |
| Dec 31, 2025 | 37.84 Mn |
| Sep 30, 2025 | 27.48 Mn |
| Jun 30, 2025 | 24.22 Mn |
| Mar 31, 2025 | 20.25 Mn |
| Dec 31, 2024 | 24.57 Mn |
| Sep 30, 2024 | 25.20 Mn |
| Jun 30, 2024 | 21.85 Mn |
| Mar 31, 2024 | 18.78 Mn |
| Dec 31, 2023 | 23.53 Mn |
| Sep 30, 2023 | 20.85 Mn |
| Jun 30, 2023 | 21.14 Mn |
| Mar 31, 2023 | 17.19 Mn |
| Dec 31, 2022 | 18.09 Mn |
| Sep 30, 2022 | 16.10 Mn |
| Jun 30, 2022 | 16.60 Mn |
| Mar 31, 2022 | 13.56 Mn |
| Dec 31, 2021 | 16.17 Mn |
| Sep 30, 2021 | 11.35 Mn |
API Access
UroGen Pharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();